-
1
-
-
0028799366
-
The National Cancer Data Base report on pancreatic cancer
-
Niederhuber JE, Brennan MF, Menck HR: The National Cancer Data Base report on pancreatic cancer. Cancer 1995; 76:1671-1677.
-
(1995)
Cancer
, vol.76
, pp. 1671-1677
-
-
Niederhuber, J.E.1
Brennan, M.F.2
Menck, H.R.3
-
2
-
-
0037258111
-
The medical management of pancreatic cancer: A review
-
McKenna S, Eatock M: The medical management of pancreatic cancer: A review. The Oncologist 2003; 8:149-160.
-
(2003)
The Oncologist
, vol.8
, pp. 149-160
-
-
McKenna, S.1
Eatock, M.2
-
3
-
-
0041335589
-
New perspectives in the management of pancreatic cancer
-
Heller DG: New perspectives in the management of pancreatic cancer. Semin Oncol 30(Suppl 11):3-10.
-
Semin Oncol
, vol.30
, Issue.SUPPL. 11
, pp. 3-10
-
-
Heller, D.G.1
-
4
-
-
0036962459
-
New Tech niques and agents in the adjuvant therapy of pancreatic cancer
-
Raraty MGT, Magee CJ, Ghaneh P, et al: New Tech niques and agents in the adjuvant therapy of pancreatic cancer. Acta Oncologica 2002; 41:582-595.
-
(2002)
Acta Oncologica
, vol.41
, pp. 582-595
-
-
Raraty, M.G.T.1
Magee, C.J.2
Ghaneh, P.3
-
5
-
-
8244254377
-
Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreatic cancer: A randomized trial
-
Burris HA, Morre MJ, Anderson J, et al: Improvements in survival and clinical benefit with gemcitabine as first line therapy for patients with advanced pancreatic cancer: A randomized trial. J Clin Oncol 1997; 15:2403-2413.
-
(1997)
J Clin Oncol
, vol.15
, pp. 2403-2413
-
-
Burris, H.A.1
Morre, M.J.2
Anderson, J.3
-
6
-
-
0035165047
-
Gemcitabine: Progress in the treatment of pancreatic cancer
-
Heinemann V: Gemcitabine: Progress in the treatment of pancreatic cancer. Oncology 2001; 60:8-18.
-
(2001)
Oncology
, vol.60
, pp. 8-18
-
-
Heinemann, V.1
-
7
-
-
0033638288
-
The role of gemcitabine alone and in combination in the treatment of pancreatic cancer
-
Oettle H, Arnold D, Hempel C, et al: The role of gemcitabine alone and in combination in the treatment of pancreatic cancer. Anti-Cancer Drugs 2000; 11:771-786.
-
(2000)
Anti-Cancer Drugs
, vol.11
, pp. 771-786
-
-
Oettle, H.1
Arnold, D.2
Hempel, C.3
-
8
-
-
8944261362
-
A phase II trial of gemcitabine in patients with 5-FU-refractory pancreatic cancer
-
Rothenberg ML, Moore MJ, Cripps MC, et al: A phase II trial of gemcitabine in patients with 5-FU-refractory pancreatic cancer. Ann Oncol 1996; 7:347-353.
-
(1996)
Ann Oncol
, vol.7
, pp. 347-353
-
-
Rothenberg, M.L.1
Moore, M.J.2
Cripps, M.C.3
-
9
-
-
0142063360
-
The experience with oxaliplatin in the treatment of upper gastrointestinal carcinomas
-
Hoff PM, Fuchs CS: The experience with oxaliplatin in the treatment of upper gastrointestinal carcinomas. Semin Oncol 2003; 30(Suppl 15):54-61.
-
(2003)
Semin Oncol
, vol.30
, Issue.SUPPL. 15
, pp. 54-61
-
-
Hoff, P.M.1
Fuchs, C.S.2
-
10
-
-
0032990022
-
Supraadditive effect of 2′, 2′-difluorodeoxycystidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines
-
Faivre S, Raymond E, Woynarowski JM, et al: Supraadditive effect of 2′, 2′-difluorodeoxycystidine (gemcitabine) in combination with oxaliplatin in human cancer cell lines. Cancer Chemother Pharmacol 1999; 44:117-123.
-
(1999)
Cancer Chemother Pharmacol
, vol.44
, pp. 117-123
-
-
Faivre, S.1
Raymond, E.2
Woynarowski, J.M.3
-
11
-
-
3142577828
-
Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: A study of the German Testicular Cancer Study Group
-
Kollmannsberger C, Beyer J, Liersch R, et al: Combination chemotherapy with gemcitabine plus oxaliplatin in patients with intensively pretreated or refractory germ cell cancer: a study of the German Testicular Cancer Study Group. J Clin Oncol 2004; 22:108-114.
-
(2004)
J Clin Oncol
, vol.22
, pp. 108-114
-
-
Kollmannsberger, C.1
Beyer, J.2
Liersch, R.3
-
12
-
-
0031012340
-
Changes in nutritional status associated with unresectable pancreatic cancer
-
Wigmore SJ, Plester CE, Richardson RA, Fearon KC: Changes in nutritional status associated with unresectable pancreatic cancer. Br J Cancer 1997; 75:106-109.
-
(1997)
Br J Cancer
, vol.75
, pp. 106-109
-
-
Wigmore, S.J.1
Plester, C.E.2
Richardson, R.A.3
Fearon, K.C.4
-
13
-
-
0026080801
-
Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes
-
Sampaio EP, Sarno EN, Galilly R, et al: Thalidomide selectively inhibits tumor necrosis factor alpha production by stimulated human monocytes. J Exp Med 1991; 173:699-703.
-
(1991)
J Exp Med
, vol.173
, pp. 699-703
-
-
Sampaio, E.P.1
Sarno, E.N.2
Galilly, R.3
-
14
-
-
15444379633
-
Thalidomide in the treatment of cancer cachexia: A randomized placebo controlled trial
-
Gordon JN, Trebble TM, Ellis RD, et al: Thalidomide in the treatment of cancer cachexia: a randomized placebo controlled trial. Gut 2005; 54:540-545.
-
(2005)
Gut
, vol.54
, pp. 540-545
-
-
Gordon, J.N.1
Trebble, T.M.2
Ellis, R.D.3
-
15
-
-
0642375736
-
The modulation of irinotecan-induced diarrhoea and pharmacokinetics by three different classes of pharmacologic agents
-
Chowbay B, Sharma A, Zhou QY, et al: The modulation of irinotecan-induced diarrhoea and pharmacokinetics by three different classes of pharmacologic agents. Oncol Rep 2003; 10:745-751.
-
(2003)
Oncol Rep
, vol.10
, pp. 745-751
-
-
Chowbay, B.1
Sharma, A.2
Zhou, Q.Y.3
-
16
-
-
0035976547
-
A scheme for a dose-escalation study when event is lagged
-
Husing J, Sauerwein W, Hideghety K, et al: A scheme for a dose-escalation study when event is lagged. Statist Med 2001; 20:3323-3334.
-
(2001)
Statist Med
, vol.20
, pp. 3323-3334
-
-
Husing, J.1
Sauerwein, W.2
Hideghety, K.3
-
17
-
-
0035884462
-
The continual reassessment method and its applications: A Bayesian methodology for phase I cancer clinical trials
-
Ishizuka N, Ohashi Y: The continual reassessment method and its applications: a Bayesian methodology for phase I cancer clinical trials. Statist Med 2001; 20:2661-2668.
-
(2001)
Statist Med
, vol.20
, pp. 2661-2668
-
-
Ishizuka, N.1
Ohashi, Y.2
-
18
-
-
0000106419
-
Synergistic interaction between cisplatin and gemcitabine in ovarian and colon cancer cell lines
-
Bergman AM, Ruiz van Haperen VWT, Veerman G, et al: Synergistic interaction between cisplatin and gemcitabine in ovarian and colon cancer cell lines. Purine Pyrimidine Metab Man 1995; 7:139-143.
-
(1995)
Purine Pyrimidine Metab Man
, vol.7
, pp. 139-143
-
-
Bergman, A.M.1
Ruiz van Haperen, V.W.T.2
Veerman, G.3
-
19
-
-
0035425508
-
Phase II study of gemcitable and cisplatin in the tratment of patients with advanced pancreatic cancer
-
Philip PA, Zalupski MM, Vaitkevicius VK, et al: Phase II study of gemcitable and cisplatin in the tratment of patients with advanced pancreatic cancer. Cancer 2001; 92:569-577.
-
(2001)
Cancer
, vol.92
, pp. 569-577
-
-
Philip, P.A.1
Zalupski, M.M.2
Vaitkevicius, V.K.3
-
20
-
-
0036682041
-
Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297
-
Berlin JD, Catalano P, Thomas JP, et al: Phase III study of gemcitabine in combination with fluorouracil versus gemcitabine alone in patients with advanced pancreatic carcinoma: Eastern Cooperative Oncology Group Trial E2297. J Clin Oncol 2002; 20:3270-3275.
-
(2002)
J Clin Oncol
, vol.20
, pp. 3270-3275
-
-
Berlin, J.D.1
Catalano, P.2
Thomas, J.P.3
-
21
-
-
0036052558
-
Cellular and molecular pharmacology of oxaliplatin
-
Raymond E, Faivre S, Chaney S, et al: Cellular and molecular pharmacology of oxaliplatin. Mol Cancer Ther 2002; 1:227-235.
-
(2002)
Mol Cancer Ther
, vol.1
, pp. 227-235
-
-
Raymond, E.1
Faivre, S.2
Chaney, S.3
-
22
-
-
0037087787
-
Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma. Final results of a GERCOR multicenter phase II study
-
Louvet C, Andre T, Lledo G, et al: Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma. Final results of a GERCOR multicenter phase II study. J Clin Oncol 2002; 20:1512-1518.
-
(2002)
J Clin Oncol
, vol.20
, pp. 1512-1518
-
-
Louvet, C.1
Andre, T.2
Lledo, G.3
-
23
-
-
9244226015
-
Hepatocellular carcinoma with intra-atrial tumor thrombi
-
Chang JY, Ka WS, Chao TY, et al: Hepatocellular carcinoma with intra-atrial tumor thrombi. Oncoly 2004; 67:320-325.
-
(2004)
Oncoly
, vol.67
, pp. 320-325
-
-
Chang, J.Y.1
Ka, W.S.2
Chao, T.Y.3
|